A randomized clinical trial of atorvastatin 10 mg and 80 mg in the reversal of or stabilization of carotid atheroma lipid pool

Trial Profile

A randomized clinical trial of atorvastatin 10 mg and 80 mg in the reversal of or stabilization of carotid atheroma lipid pool

Discontinued
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2007

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atherosclerosis
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 25 Jul 2007 Status changed from recruiting to discontinued. The study was terminated on June 22, 2007 for inability to enroll patients within an appropriate timeframe.
    • 21 Jul 2007 Status changed back to recruiting.
    • 18 Jun 2007 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top